Search Results 1331-1340 of 19434 for Hemoglobin

1. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

   Hemoglobin ≥ 8 g/dL; Platelets ˃75,000/mm³; Creatinine clearance ≥ 50 mL/min, calculated with the use of 24-hour creatinine clearance or by Cockcroft-Gault ...

2. A Study to Evaluate Ulixertinib to Treat Patients with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Platelets ≥ 100 x 10^9 cells/L;; Absolute neutrophil count ≥ 1.5 x 10^9 cells/L). Adequate cardiac function: Left ventricular ...

3. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

   Hemoglobin ≥ 7.0 g/dL;; Platelets ≥ 50 x 10^9/L;; Total bilirubin ≤ 1.5 x Upper limit of normal (ULN) (Isolated bilirubin ≥ 1.5 x ULN is acceptable if ...

4. A Trial of the Effectiveness and Safety of CVL-865 to Treat Focal Onset Seizures - Mayo Clinic

   Participation eligibility · AST or ALT ≥ 2 x ULN; · Total bilirubin ≥ 1.5 x ULN. · Females: Hemoglobin < 11 g/dL | Males: hemoglobin < 12 g/dL; · White blood cell ...

5. A Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure - Mayo Clinic

   Severe anemia (Hemoglobin < 10 g/dL). Severe hepatic disease. Complex congenital heart disease. Listed for cardiac transplantation. Other class I ...

6. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Latiglutenase to Treat Patients with Well-Controlled Celiac Disease - Mayo Clinic

   Hemoglobin < 10 g/dL or 100 g/L;; Calcium < 8.0 mg/mL;; Platelet count< 75.0 x 109/L or 75,000/mm3;; Partial thromboplastin time (PTT) or prothrombin time (PT ...

7. Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma - Mayo Clinic

   Hemoglobin ≥ 10 g/dL (RBC transfusion allowed); Not pregnant or nursing; Negative pregnancy test; Fertile patients must use contraception; No known HIV ...

8. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x IULN; AST(SGOT)/ALT(SGPT) ≤ 2.5 x IULN, or ≤ 5.0 x IULN if due to liver involvement by tumor; Creatinine ...

9. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Subject has a history of diabetes mellitus type 1, or uncontrolled diabetes mellitus type 2 with hemoglobin A1c (HbA1c) > 9%, or is a diabetic subject with ...

10. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    Absolute neutrophil count ≥ 1,000 cells/mm3 without growth factors (within 14 days of enrollment). Hemoglobin ≥ 8 g/dL (within 14 days of enrollment) ...